RO6864018

DRUG2 trials

Sponsors

Hoffmann-La Roche

Conditions

Healthy VolunteerHepatitis B, Chronic

Phase 1

A Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of RO6864018 in Male, Healthy, Asian Participants

CompletedNCT02015715

Hoffmann-La RocheHealthy Volunteer

Start: 2013-12-31End: 2014-11-30Updated: 2017-03-01

Phase 2

A Study of Treatment With RO6864018 in Virologically Suppressed Participants With Chronic Hepatitis B Virus (HBV) Infection

CompletedNCT02391805

Hoffmann-La RocheHepatitis B, Chronic

Start: 2015-05-17End: 2017-10-16Updated: 2018-06-06